← All stocks

AbCellera Biologics Inc.

ABCL Net buying

CIK 0001703057 #1583 in the set updated 17 Sep 2026

Bought (12 mo)

$2.68M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$2.68M

+$2.68M against sales at will

By person

5 insiders · 10 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hayden Michael R

Director

$1.05M (2)

—

+$1.05M

1,373,397

0.4479%

$14.61M

+3.8%

Thermopylae Holdings Ltd. entity

10% owner

$711.00K (2)

—

+$711.00K

56,134,097

18.31%

$597.27M

+0.1%

Booth Andrew

Chief Financial Officer

$529.60K (2)

—

+$529.60K

482,800

0.1575%

$5.14M

+215.6%

Montalbano John S.

Director

$384.16K (3)

—

+$384.16K

251,000

0.0819%

$2.67M

+191.9%

Hansen Carl L. G.

Chief Executive Officer

—

898,000

0.2929%

$9.55M

+14.3%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 22

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 525,000

History held since 17 Dec 2020